Partner Preview · Concept website for discussion only · Not yet approved for public medical advertising
Gangnam JS Hospital · Seoul, Korea

Preserve your natural knee. Protect your active life.

A private Thailand referral concept for advanced joint-preservation treatment at Gangnam JS Hospital — beginning with specialist review of MRI, X-ray and medical history before any treatment decision.

Current treatment range
USD 50,000–70,000 per treated joint. Includes surgery, approximately one month of hospitalization, treatment, meals and follow-up care. Air ticket is not included. Additional costs may apply when medically required or requested by the patient.
≈3,000surgeries stated in hospital materials
SCIpublished research referenced
Seoul122 Dogok-ro, Gangnam-gu
Candidate-first approachNo promise of cure. Suitability and expected outcomes must be determined by the treating orthopedic team.
Why Gangnam JS

A specialist story built on joint preservation.

The hospital's 2026 international-patient material positions Gangnam JS around stem-cell-based joint regeneration, evidence-based treatment and international patient experience.

≈3,000

Clinical experience

The hospital presentation states approximately 3,000 surgeries performed at Gangnam JS Hospital.

SCI

Scientific validation

Hospital materials state that multiple international SCI papers have been published regarding safety and efficacy.

Global

International patient experience

The 2026 case material highlights patients and medical outreach across the Middle East, Americas and Asia.

Treatment positioning

First answer one question: Is the patient a suitable candidate?

This concept intentionally avoids 'miracle cure' messaging. The first commercial step is medical screening — not selling surgery.

Potential discussion points

  • Degenerative or traumatic articular cartilage damage — as stated in hospital materials
  • Patients who want a specialist opinion on joint-preservation options
  • Patients able to provide current MRI and lower-extremity X-ray images

What we will not promise

  • No '100% cure' or money-back medical guarantee
  • No claim that every knee patient can avoid artificial joint replacement
  • No FDA-approval claim unless exact regulatory wording is documented and approved for Thailand use
Thailand → Korea → Thailand

A clear patient journey removes uncertainty.

The current treatment arrangement includes approximately one month of hospitalization and treatment in Korea. Air ticket is not included. Final treatment needs and any additional costs depend on the individual patient’s condition and requests.

1

Send MRI + X-ray

Thailand patient desk organizes files for preliminary specialist review.

2

Video consultation

The Korean physician explains suitability, options, risks and expected rehabilitation.

3

Travel to Seoul

Pre-operative assessment and final treatment plan at Gangnam JS Hospital.

4

Treatment + recovery

The package includes surgery, approximately one month of hospitalization, treatment, meals and recovery care in Korea.

5

Thailand follow-up

Follow-up care includes a planned visit to Thailand by the operating surgeon approximately 3–4 months after surgery, subject to the patient’s clinical situation and scheduling.

Current referral treatment range

A premium medical program with clearly stated inclusions.

The current referral range is USD 50,000–70,000 per treated joint. The final amount depends on the patient’s condition and any additional treatment or requests. Air ticket is not included.

CURRENT REFERRAL RANGE
USD 50K–70K / treated joint
✓ Included
Surgery
✓ Included
Approx. 1 month hospitalization
✓ Included
Treatment & recovery care
✓ Included
Meals during hospitalization
✓ Included
Follow-up care
✓ Included
Operating surgeon visit to Thailand, approx. 3–4 months after surgery
✕ Not included
Air ticket
Variable
Additional treatment or patient-requested services, if required
Cost guidance
Minimum: USD 50,000 per treated joint. Standard upper range: USD 70,000 per treated joint. Additional costs may apply if the patient’s condition requires further treatment or if the patient requests additional services. Final medical recommendations and costs must be confirmed for each individual case.
Thailand market-entry approach

Begin with trusted private referrals — not mass advertising.

The proposed first phase is a controlled referral pilot among trusted personal and professional networks. The objective is to introduce a small number of suitable Thai patients, observe the treatment experience and outcomes, and learn from patient feedback before deciding whether to establish a formal Thailand agent operation.

1

Trusted introduction

Start with acquaintances and trusted contacts who have a genuine joint-treatment need.

2

Clinical screening

MRI, X-ray and medical history are reviewed by the Korean medical team before any treatment decision.

3

Pilot cases

Refer a limited number of Thai patients and carefully observe the real patient journey.

4

Evaluate results

Review outcomes, patient satisfaction, operational issues and genuine market demand.

5

Formalize only if justified

If the pilot is convincing, then consider a formal Thailand agent company, compliant marketing and scaled operations.

Hospital case material

International cases can build trust — if used carefully.

The hospital's 2026 international-patient presentation includes these examples. Commercial use of names, photos and testimonials in Thailand should be confirmed with the hospital before publication.

Guus Hiddink

Hospital materials state right-knee stem-cell implantation in 2014 and left-knee implantation in 2022.

Sheikh Faisal Bin Qassim Al Thani

The hospital presentation states that he underwent stem-cell surgery at Gangnam JS in April 2024.

International Outreach

The 2026 deck highlights ongoing medical consultations and outreach in the Middle East, Americas and Asia.

Private referral intake

Start with a private clinical review, not a public sales pitch.

This private referral form shows how a Thailand patient coordinator could prepare a referred case for preliminary review by the Korean medical team.